Entry |
|
Name |
Remetinostat (USAN/INN) |
Formula |
C16H21NO6
|
Exact mass |
323.1369
|
Mol weight |
323.34
|
Structure |

|
Class |
Antineoplastic
DG03133 Histone deacetylase inhibitor
|
Efficacy |
Antineoplastic, Histone deacetylase inhibitor |
Comment |
Treatment of early-stage cutaneous T-cell lymphoma
|
Target |
|
Pathway |
|
Brite |
Drug groups [BR:br08330]
Antineoplastic
DG03133 Histone deacetylase inhibitor
D10977 Remetinostat
Target-based classification of drugs [BR:br08310]
Enzymes
Hydrolases (EC3)
Histone deacetylase
HDAC
D10977 Remetinostat (USAN/INN)
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 23
1 O7a O 14.7700 -12.3200
2 C7a C 15.9824 -13.0200
3 C1b C 17.1949 -12.3200
4 C1b C 18.4073 -13.0200
5 C1b C 19.6197 -12.3200
6 C1b C 20.8322 -13.0200
7 C1b C 22.0446 -12.3200
8 C1b C 23.2570 -13.0200
9 C5a C 24.4695 -12.3200
10 N1b N 25.6819 -13.0200
11 O1b O 26.8944 -12.3200
12 C8y C 13.5576 -13.0200
13 C8x C 12.3621 -12.3296
14 C8x C 11.1496 -13.0295
15 C8y C 11.1494 -14.4295
16 C8x C 12.3449 -15.1199
17 C8x C 13.5574 -14.4200
18 C7a C 9.9266 -15.1354
19 O7a O 8.7177 -14.4374
20 O6a O 9.9267 -16.5199
21 C1a C 7.5370 -15.1190
22 O6a O 15.9824 -14.4198
23 O5a O 24.4695 -10.9203
BOND 23
1 1 2 1
2 2 3 1
3 3 4 1
4 4 5 1
5 5 6 1
6 6 7 1
7 7 8 1
8 8 9 1
9 9 10 1
10 10 11 1
11 1 12 1
12 12 13 2
13 13 14 1
14 14 15 2
15 15 16 1
16 16 17 2
17 12 17 1
18 15 18 1
19 18 19 1
20 18 20 2
21 19 21 1
22 2 22 2
23 9 23 2
|